English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 24 January 2023, 21:00 HKT/SGT
Share:
    

Source: Broadhill Capital
Broadhill Capital Announces its Capital Deployment Strategy for 2023

LOS ANGELES, CA, Jan 24, 2023 - (ACN Newswire) - Broadhill Capital announced today that the firm will target to commit equity investment of USD $15 Billion across approximately 100-150 businesses.

"We expect to make non-control equity investments into businesses that have the potential to achieve 5-10x revenue growth with our capital commitment," stated investment committee member Francis König. "We separate ourselves by our willingness to assist businesses in situations that often appear high risk to more conservative investors."

Investment commitments are expected to range between USD $50 Million to $5 Billion per company, with most falling between USD $100-500 Million. Businesses must either be public or be positioned and agree to become publicly listed on a major global stock exchange within 3 years. Most business types, industries, and geographies are eligible, provided the business activities are legal in the United States, and in the countries where the business operates. Due diligence and transaction approval should typically be completed within 30 days.

Businesses seeking equity investment may submit their opportunity for immediate consideration through the BroadhillCapital.com website by using the link: https://broadhillcapital.com/submit-business/.

Source: Broadhill Capital LLC
Media Contact: press@broadhillcapital.com

Topic: Press release summary
Source: Broadhill Capital

Sectors: Daily Finance, PE, VC & Alternatives, Trade Finance
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Six Tips for building a website that really works for your business  
Apr 17, 2024 10:30 HKT/SGT
ZOETIS (ZTS) Investor Alert: Kaplan Fox & Kilsheimer LLP Investigates Zoetis Inc. for Potential Securities Law Violations   
Apr 17, 2024 09:40 HKT/SGT
ZOETIS (ZTS): Kaplan Fox & Kilsheimer LLP Investigates Zoetis and Encourages Investors with Losses to Contact the Firm  
Apr 17, 2024 08:11 HKT/SGT
Elevating Possibilities: The Countdown for WBS Dubai Begins!  
Apr 16, 2024 23:33 HKT/SGT
Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study  
Apr 16, 2024 21:10 HKT/SGT
InnoEX, Spring Electronics Fair boost tech hub status  
Apr 16, 2024 19:24 HKT/SGT
CleverTap bags ten prestigious awards at the 2024 Stevie Awards   
Apr 16, 2024 19:00 HKT/SGT
Lexus presents Time at the 2024 Milan Design Week  
Tuesday, April 16, 2024 5:49:00 PM
SinoMab BioScience preclinical results of SM17 on atopic dermatitis (AD) published on International Scientific Journal Allergy  
Apr 16, 2024 17:35 HKT/SGT
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology  
Apr 16, 2024 17:04 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575